Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution.

Conclusions The risk of stroke or death and degree of clinical impairment among treated patients was lower than reported in ARUBA. The authors found no significant difference in outcomes between observed and treated ARUBA-eligible patients at UCSF. Results in ARUBA-eligible patients managed outside that trial led to an entirely different conclusion about AVM intervention, due to the primary role of surgery, judicious surgical selection with established outcome predictors, and technical expertise developed at high-volume AVM centers. PMID: 25175446 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25175446?dopt=Abstract

Source: Neurosurgical Focus - September 1, 2014 Category: Neurosurgery Authors: Rutledge WC, Abla AA, Nelson J, Halbach VV, Kim H, Lawton MT Tags: Neurosurg Focus Source Type: research